Evidence map›Paper›PMID 28833307›Full record

ArticleStatistics in medicine2017

A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance.

Joseph Antonelli, Bing Han, Matthew Cefalu

Abstract read
In one paragraph

Article in Statistics in medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joseph AntonelliDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, 655 Huntington Avenue, Boston, MA 02115, U.S.A.ORCID http://orcid.org/0000-0001-7464-5766
Bing HanRAND Corporation, 1776 Main Street, Santa Monica, CA 90401, U.S.A.
Matthew CefaluRAND Corporation, 1776 Main Street, Santa Monica, CA 90401, U.S.A.

Funding

Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI JAIME ELIZABETH HART · 1985 to 2026
$44.6M
GRADUATE TRAINING IN BIOSTATISTICST32ES007142 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Brent Andrew Coull · 1985 to 2026
$11.9M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Statistical Methods for the Spatio-Temporal Assessment of Social Disparities in CancerP01CA134294 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI HANEUSE, SEBASTIEN, HERNAN, MIGUEL · 2008 to 2017
$6.8M
Project 3: Cumulative Risk and Geospatial Health Disparities Related to Chemical and Non-Chemical Stressor ExposuresP50MD010428 · NIMHD · HARVARD SCHOOL OF PUBLIC HEALTH · PI LADEN, FRANCINE, LEVY, JONATHAN I · 2015 to 2020
$4.0M
Cardiovascular Health and Air Pollution: A National StudyR01ES024332 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI ZANOBETTI, ANTONELLA · 2015 to 2018
$2.5M
Bayesian Methods for Comparative Effectiveness Research with Observational DataR01GM111339 · NIGMS · HARVARD MEDICAL SCHOOL · PI NORMAND, SHARON-LISE TERESA · 2015 to 2018
$2.5M
Causal Inference with Interference for Evaluating Air Quality PoliciesR01ES026217 · NIEHS · UNIVERSITY OF TEXAS AT AUSTIN · PI ZIGLER, CORWIN MATTHEW · 2016 to 2021
$2.2M
A Model Averaging Approach to Causal Inference in Substance Abuse Prevention ResearchR01DA040721 · NIDA · RAND CORPORATION · PI HAN, BING · 2016 to 2018
$808k
NCI NIH HHS P01 CA134294NCI NIH HHS R35 CA197449NIDA NIH HHS R01 DA040721NIEHS NIH HHS P30 ES000002NIEHS NIH HHS R01 ES024332NIEHS NIH HHS R01 ES026217NIEHS NIH HHS T32 ES007142NIGMS NIH HHS R01 GM111339NIMHD NIH HHS P50 MD010428
6 · The paper itself

Abstract

A critical issue in the analysis of clinical trials is patients' noncompliance to assigned treatments. In the context of a binary treatment with all or nothing compliance, the intent-to-treat analysis is a straightforward approach to estimating the effectiveness of the trial. In contrast, there exist 3 commonly used estimators with varying statistical properties for the efficacy of the trial, formally known as the complier-average causal effect. The instrumental variable estimator may be unbiased but can be extremely variable in many settings. The as treated and per protocol estimators are usually more efficient than the instrumental variable estimator, but they may suffer from selection bias. We propose a synthetic approach that incorporates all 3 estimators in a data-driven manner. The synthetic estimator is a linear convex combination of the instrumental variable, per protocol, and as treated estimators, resembling the popular model-averaging approach in the statistical literature. However, our synthetic approach is nonparametric; thus, it is applicable to a variety of outcome types without specific distributional assumptions. We also discuss the construction of the synthetic estimator using an analytic form derived from a simple normal mixture distribution. We apply the synthetic approach to a clinical trial for post-traumatic stress disorder.

Indexed as

Linear ModelsPatient ComplianceResearch SubjectsBiasClinical Trials as TopicComputer SimulationHumansRandomized Controlled Trials as TopicStress Disorders, Post-TraumaticTreatment Outcomecausal inferenceclinical trialsmodel averagingnoncomplianceprinciple stratification

Identifiers

PMID28833307
PMCPMC5698094

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.